Early detection of hepatocellular carcinoma through surveillance using biomarkers

Gastroenterology and Hepatology

Volumn 10, Issue 2, 2014, Pages 121-123

  Gish, Robert G ^a  

^a LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ REACTIVE FRACTION OF ALPHA FETOPROTEIN; ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; EARLY DIAGNOSIS; HUMAN; LIVER CELL CARCINOMA; PREVALENCE;

EID: 84896706005     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Lok AS, Sterling RK, Everhart JE, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010;138(2):493-502.
2. Tamura Y, Suda T, Arii S, et al. Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci. 2013;58(8):2406-2412.
3. Toyoda H, Kumada T, Kiriyama S, et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2006;4(1):111-117.
4. Volk ML, Hernandez JC, Su GL, Lok AS, Marrero JA. Risk factors for hepatocel'lular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark. 2007;3(2):79-87.